Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2889) 2889
Publication (308) 308
Newsletter (157) 157
Book Review (98) 98
Newspaper Article (94) 94
Book Chapter (38) 38
Magazine Article (26) 26
Book / eBook (16) 16
Trade Publication Article (14) 14
Dissertation (13) 13
Government Document (7) 7
Conference Proceeding (6) 6
Report (2) 2
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
influenza (2077) 2077
index medicus (1944) 1944
humans (1906) 1906
viruses (1243) 1243
animals (1202) 1202
infectious diseases (769) 769
virology (722) 722
female (705) 705
vaccines (704) 704
pandemics (690) 690
influenza, human - virology (668) 668
immunology (643) 643
antiviral agents - pharmacology (626) 626
health aspects (626) 626
influenza viruses (611) 611
research (608) 608
infections (604) 604
medicine (595) 595
research article (594) 594
influenza vaccines (574) 574
microbiology (560) 560
male (546) 546
influenza, human - prevention & control (529) 529
vaccination (508) 508
virus diseases (508) 508
influenza, human - epidemiology (504) 504
multidisciplinary sciences (494) 494
mice (483) 483
influenza vaccines - immunology (468) 468
infection (463) 463
science (459) 459
influenza a virus, h3n2 subtype - drug effects (445) 445
adult (441) 441
influenza a virus, h1n1 subtype - drug effects (417) 417
influenza, human - drug therapy (375) 375
middle aged (369) 369
dogs (368) 368
antiviral agents (358) 358
proteins (358) 358
oseltamivir (352) 352
mutation (348) 348
influenza a virus, h1n1 subtype - immunology (347) 347
analysis (341) 341
adolescent (336) 336
immunization (336) 336
epidemics (333) 333
biology (325) 325
avian influenza (322) 322
influenza a virus (316) 316
influenza vaccines - administration & dosage (316) 316
public health (315) 315
antiviral agents - therapeutic use (309) 309
a virus (305) 305
aged (304) 304
hemagglutinin (303) 303
cell line (293) 293
child (293) 293
avian flu (275) 275
prevention (274) 274
influenza, human - immunology (273) 273
pharmacology & pharmacy (267) 267
child, preschool (265) 265
influenza a (259) 259
mortality (259) 259
seasons (253) 253
influenza a virus, h1n1 subtype - genetics (249) 249
influenza a virus, h3n2 subtype - immunology (249) 249
swine flu (247) 247
children (246) 246
immunity (242) 242
antigens (241) 241
young adult (240) 240
immune response (239) 239
viral diseases (236) 236
drug resistance (235) 235
epidemiology (231) 231
virus (227) 227
surveillance (225) 225
influenza a virus, h3n2 subtype - genetics (224) 224
united-states (221) 221
influenza a virus - drug effects (220) 220
influenza virus (220) 220
drug resistance, viral (218) 218
medical research (214) 214
viral infections (213) 213
immunogenicity (209) 209
oseltamivir - pharmacology (209) 209
article (207) 207
antibodies, viral - blood (203) 203
mice, inbred balb c (203) 203
infant (202) 202
orthomyxoviridae infections - virology (201) 201
neuraminidase - antagonists & inhibitors (200) 200
genetic aspects (191) 191
vaccine (190) 190
antibodies (189) 189
madin darby canine kidney cells (188) 188
replication (187) 187
drug therapy (186) 186
care and treatment (185) 185
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (8) 8
Online Resources - Online (3) 3
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Not Returned (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3192) 3192
Russian (40) 40
Chinese (11) 11
Japanese (5) 5
French (3) 3
German (2) 2
Spanish (2) 2
Hungarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide
by Varough M. Deyde and Xiyan Xu and Rick A. Bright and Michael Shaw and Catherine B. Smith and Ye Zhang and Yuelong Shu and Larisa V. Gubareva and Nancy J. Cox and Alexander I. Klimov
The Journal of Infectious Diseases, ISSN 0022-1899, 7/2007, Volume 196, Issue 2, pp. 249 - 257
Our previous reports demonstrated an alarming increase in resistance to adamantanes among influenza A(H3N2) viruses isolated in 2001-2005. To continue... 
Influenza A virus | Antivirals | Phylogenetics | Viruses | Amino acids | Orthomyxoviridae | Evolution | Infections | Preventive medicine | Drug resistance | UNITED-STATES | INFECTIOUS DISEASES | PANDEMIC INFLUENZA | RIMANTADINE | MICROBIOLOGY | IMMUNOLOGY | CHILDREN | NEURAMINIDASE INHIBITORS | A VIRUSES | FAMILIES | FREQUENCY | AMANTADINE | INFECTION | Antiviral Agents - pharmacology | Global Health | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Drug Resistance, Viral | Influenza A Virus, H3N2 Subtype - genetics | Phylogeny | Influenza A Virus, H1N1 Subtype - drug effects | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Microbial Sensitivity Tests | Amantadine - pharmacology | Influenza A Virus, H1N1 Subtype - genetics | Sentinel Surveillance | Rimantadine - pharmacology | Influenza viruses | Prevention | Amantadine | Analysis | Influenza | Patient outcomes | Development and progression | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008
by Tiffany G. Sheu and Varough M. Deyde and Margaret Okomo-Adhiambo and Rebecca J. Garten and Xiyan Xu and Rick A. Bright and Eboneé N. Butler and Teresa R. Wallis and Alexander I. Klimov and Larisa V. Gubareva
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2008, Volume 52, Issue 9, pp. 3284 - 3292
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
IMMUNOCOMPROMISED CHILD | ASSAY | ACTIVE-SITE | ZANAMIVIR | SUSCEPTIBILITY NETWORK | ADAMANTANE RESISTANCE | POSITION STATEMENT | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MUTATIONS | REDUCED SENSITIVITY | OSELTAMIVIR | Cell Line | Influenza B virus - enzymology | Antiviral Agents - pharmacology | Influenza A Virus, H3N2 Subtype - enzymology | Global Health | Influenza A Virus, H3N2 Subtype - drug effects | Antiviral Agents - therapeutic use | Oseltamivir - therapeutic use | Humans | Drug Resistance, Viral | Neuraminidase - genetics | Influenza, Human - epidemiology | Influenza A Virus, H3N2 Subtype - genetics | Influenza A Virus, H1N1 Subtype - drug effects | Influenza B virus - genetics | Animals | Influenza A Virus, H1N1 Subtype - enzymology | Influenza, Human - virology | Neuraminidase - antagonists & inhibitors | Influenza B virus - drug effects | Seasons | Influenza A Virus, H1N1 Subtype - genetics | Population Surveillance | Oseltamivir - pharmacology | Antiviral Agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
by Bright, Rick A and Shay, David K and Shu, Bo and Cox, Nancy J and Klimov, Alexander I
JAMA, ISSN 0098-7484, 02/2006, Volume 295, Issue 8, pp. 891 - 894
CONTEXT The adamantanes, amantadine and rimantadine, have been used as first-choice antiviral drugs against community outbreaks of influenza A viruses for many... 
PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | TRANSMISSION | NEURAMINIDASE INHIBITORS | H3N2 VIRUSES | FAMILIES | SUSCEPTIBILITY | RIMANTADINE | AMANTADINE | INFECTION | EMERGENCE | Adamantane - pharmacology | Antiviral Agents - pharmacology | Viral Matrix Proteins - genetics | Influenza A Virus, H3N2 Subtype - drug effects | United States | Humans | Influenza A virus - genetics | Influenza A Virus, H3N2 Subtype - genetics | Influenza A Virus, H1N1 Subtype - drug effects | Drug Resistance, Viral - genetics | Biological Assay | Influenza, Human - drug therapy | Mutation | Seasons | Sequence Analysis | Influenza A virus - drug effects | Influenza A Virus, H1N1 Subtype - genetics | Antiviral agents | Usage | Viruses | Data analysis | Infectious diseases | Drug resistance | Disease control | Influenza
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text NS1 protein mutation I64T affects interferon responses and virulence of circulating H3N2 human influenza A viruses
by DeDiego, Marta L and Nogales, Aitor and Lambert-Emo, Kris and Martinez-Sobrido, Luis and Topham, David J
Journal of Virology, ISSN 0022-538X, 2016, Volume 90, Issue 21, pp. 9693 - 9711
Influenza NS1 protein is the main viral protein counteracting host innate immune responses, allowing the virus to efficiently replicate in interferon... 
CPSF30 BINDING | CELLS | INHIBITION | VIROLOGY | VACCINE APPROACH | PRE-MESSENGER-RNAS | RIG-I | BETA-INTERFERON | LARGE GENE LISTS | EXPRESSION | H1N1 | Virulence - drug effects | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Immunity, Innate - genetics | Cercopithecus aethiops | Influenza A Virus, H3N2 Subtype - genetics | Leukocytes, Mononuclear - virology | HEK293 Cells | Immune Evasion - genetics | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Vero Cells | A549 Cells | Cell Line | Antiviral Agents - pharmacology | Interferons - pharmacology | Influenza A Virus, H3N2 Subtype - pathogenicity | Viral Nonstructural Proteins - genetics | Influenza A Virus, H1N1 Subtype - pathogenicity | Influenza A Virus, H1N1 Subtype - drug effects | Mutation - genetics | Animals | Immune Evasion - drug effects | RNA, Double-Stranded - genetics | Cell Line, Tumor | Cleavage And Polyadenylation Specificity Factor - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Distinct Effects of T-705 (Favipiravir) and ribavirin on influenza virus replication and Viral RNA Synthesis
by Vanderlinden, Evelien and Vrancken, Bram and Houdt, Jeroen Van and Rajwanshi, Vivek K and Gillemot, Sarah and Andrei, Graciela and Lemey, Philippe and Naesens, Lieve
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2016, Volume 60, Issue 11, pp. 6679 - 6691
T-705 (favipiravir) is a new antiviral agent in advanced clinical development for influenza therapy. It is supposed to act as an alternative substrate for the... 
NUCLEOTIDE POOL | IN-VITRO | NEURAMINIDASE INHIBITORS | MECHANISM | TRANSCRIPTION | BIOLOGICAL EVALUATION | POLYMERASE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | ANTIVIRAL AGENT | LETHAL MUTAGENESIS | DNA-Directed RNA Polymerases - antagonists & inhibitors | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Influenza A Virus, H3N2 Subtype - metabolism | Reassortant Viruses - genetics | Reassortant Viruses - drug effects | Structure-Activity Relationship | Influenza A Virus, H3N2 Subtype - genetics | IMP Dehydrogenase - genetics | Influenza A Virus, H1N1 Subtype - growth & development | Viral Proteins - metabolism | Influenza A Virus, H3N2 Subtype - growth & development | RNA, Viral - antagonists & inhibitors | Antiviral Agents - chemistry | Madin Darby Canine Kidney Cells | Influenza A Virus, H1N1 Subtype - genetics | Influenza A Virus, H1N1 Subtype - metabolism | Amides - pharmacology | A549 Cells | Virus Replication - drug effects | Antiviral Agents - pharmacology | Reassortant Viruses - metabolism | RNA, Viral - biosynthesis | Viral Proteins - genetics | Viral Proteins - antagonists & inhibitors | DNA-Directed RNA Polymerases - genetics | Ribavirin - chemistry | Influenza A Virus, H1N1 Subtype - drug effects | Chick Embryo | Reassortant Viruses - growth & development | IMP Dehydrogenase - metabolism | Pyrazines - chemistry | Animals | Mutation - drug effects | Sequence Analysis, RNA | IMP Dehydrogenase - antagonists & inhibitors | Gene Expression Regulation, Viral | Dogs | Amides - chemistry | DNA-Directed RNA Polymerases - metabolism | Pyrazines - pharmacology | Ribavirin - pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children
by Iain Stephenson and Jane Democratis and Angie Lackenby and Teresa McNally and James Smith and Manish Pareek and Joanna Ellis and Alison Bermingham and Karl Nicholson and Maria Zambon
Clinical Infectious Diseases, ISSN 1058-4838, 2/2009, Volume 48, Issue 4, pp. 389 - 396
Background. Oseltamivir, a specific influenza neuraminidase inhibitor, is an effective treatment for seasonal influenza. Emergence of drug-resistant influenza... 
Cercopithecine herpesvirus 1 | Influenza A virus | Reverse transcriptase polymerase chain reaction | Articles and Commentaries | Antivirals | Viruses | Orthomyxoviridae | Children | Drug resistance | Inhibitory concentration 50 | H3N2 subtype influenza A virus | WORLDWIDE | INFECTIOUS DISEASES | MUTANTS | DESIGN | REPLICATION | SURVEILLANCE | MICROBIOLOGY | VIRUSES RESISTANT | IMMUNOLOGY | REDUCED SENSITIVITY | Influenza A Virus, H3N2 Subtype - drug effects | Oseltamivir - therapeutic use | Humans | Influenza A virus - genetics | Drug Resistance, Viral | Child, Preschool | Neuraminidase - genetics | Infant | Male | Influenza A Virus, H3N2 Subtype - genetics | Viral Load | Microbial Sensitivity Tests | Influenza B virus - genetics | Influenza A Virus, H1N1 Subtype - isolation & purification | Influenza A Virus, H3N2 Subtype - isolation & purification | Female | Influenza, Human - virology | Influenza B virus - drug effects | Influenza, Human - drug therapy | Child | Influenza A Virus, H1N1 Subtype - genetics | Antiviral Agents - therapeutic use | Influenza B virus - isolation & purification | Viral Proteins - genetics | Influenza A virus - isolation & purification | Influenza A Virus, H1N1 Subtype - drug effects | Sequence Analysis, DNA | Influenza A virus - drug effects | Influenza | Patient outcomes | Reports | Drug therapy | Diseases | Virology | Children & youth
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase
by Giulia Muratore and Laura Goracci and Beatrice Mercorelli and Ágnes Foeglein and Paul Digard and Gabriele Cruciani and Giorgio Palù and Arianna Loregian
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2012, Volume 109, Issue 16, pp. 6247 - 6252
Influenza viruses are the cause of yearly epidemics and occasional pandemics that represent a significant challenge to public health. Current control... 
Proteins | Molecules | Influenza A virus | RNA | Molecular interactions | Antivirals | Viruses | Orthomyxoviridae | Cytotoxicity | Inhibitory concentration 50 | COMPLEX-FORMATION | IN-VITRO | NEURAMINIDASE INHIBITORS | REPLICATION | PB1 PROTEIN | STRUCTURAL BASIS | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | PA-BINDING | PEPTIDE | RNA-POLYMERASE | Small Molecule Libraries - pharmacology | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Influenza A virus - genetics | RNA Replicase - metabolism | Drug Resistance, Viral | Influenza A Virus, H3N2 Subtype - metabolism | Green Fluorescent Proteins - genetics | Influenza A Virus, H3N2 Subtype - genetics | Protein Subunits - metabolism | Influenza B virus - genetics | Protein Binding - drug effects | HEK293 Cells | Inhibitory Concentration 50 | Influenza B virus - drug effects | Influenza A Virus, H1N1 Subtype - genetics | Influenza A Virus, H1N1 Subtype - metabolism | Vero Cells | Oseltamivir - pharmacology | Protein Structure, Tertiary | Cell Line | Cell Survival - drug effects | Green Fluorescent Proteins - metabolism | Antiviral Agents - pharmacology | Cells, Cultured | Models, Molecular | Influenza A Virus, H1N1 Subtype - drug effects | Microscopy, Confocal | Animals | Influenza A virus - metabolism | RNA Replicase - chemistry | Cell Line, Tumor | Influenza B virus - metabolism | Protein Subunits - chemistry | Influenza A virus - drug effects | Influenza viruses | Disease transmission | Viral genetics | Transferases | Physiological aspects | Genetic aspects | Research | Health aspects | Cell culture | RNA polymerase | Influenza | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text New Small Molecule Entry Inhibitors Targeting Hemagglutinin-Mediated Influenza A Virus Fusion
by Arnab Basu and Aleksandar Antanasijevic and Minxiu Wang and Bing Li and Debra M. Mills and Jessica A. Ames and Peter J. Nash and John D. Williams and Norton P. Peet and Donald T. Moir and Mark N. Prichard and Kathy A. Keith and Dale L. Barnard and Michael Caffrey and Lijun Rong and Terry L. Bowlin
Journal of Virology, ISSN 0022-538X, 02/2014, Volume 88, Issue 3, pp. 1447 - 1460
Classifications Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
MEMBRANE-FUSION | ANTIBODIES | H5N1 | VIROLOGY | PANDEMIC INFLUENZA | INFECTION | DRUG-RESISTANCE | RESISTANT INFLUENZA | H1N1 VIRUS | HEMORRHAGIC-FEVER ARENAVIRUSES | OSELTAMIVIR | Small Molecule Libraries - pharmacology | Influenza A Virus, H3N2 Subtype - drug effects | Influenza A Virus, H5N1 Subtype - physiology | Humans | Influenza A virus - genetics | Influenza A Virus, H1N1 Subtype - physiology | Influenza A Virus, H5N1 Subtype - genetics | Influenza A Virus, H3N2 Subtype - genetics | Virus Internalization - drug effects | Antiviral Agents - chemistry | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Cell Line | Influenza A virus - physiology | Antiviral Agents - pharmacology | Hemagglutinins, Viral - metabolism | Hemagglutinins, Viral - genetics | Influenza A Virus, H5N1 Subtype - drug effects | Poultry Diseases - virology | Influenza A Virus, H1N1 Subtype - drug effects | Small Molecule Libraries - chemistry | Animals | Chickens | Influenza in Birds - virology | Influenza A Virus, H3N2 Subtype - physiology | Influenza A virus - drug effects | Vaccines and Antiviral Agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The epidemiology and spread of drug resistant human influenza viruses
by Hurt, Aeron C
Current Opinion in Virology, ISSN 1879-6257, 10/2014, Volume 8, pp. 22 - 29
Significant changes in the circulation of antiviral-resistant influenza viruses have occurred over the last decade. The emergence and continued circulation of... 
UNITED-STATES | NEURAMINIDASE INHIBITOR RESISTANCE | SOUTH EAST-ASIA | VIROLOGY | ANTIVIRAL RESISTANCE | OSELTAMIVIR-RESISTANT | A VIRUSES | COMMUNITY CLUSTER | ADAMANTANE RESISTANCE | ISOLATED WORLDWIDE | AMANTADINE RESISTANCE | Adamantane - pharmacology | Antiviral Agents - pharmacology | Influenza A Virus, H3N2 Subtype - drug effects | Antiviral Agents - therapeutic use | Oseltamivir - therapeutic use | Humans | Virulence | Drug Resistance, Viral | Influenza A Virus, H1N1 Subtype - physiology | Neuraminidase - genetics | Viral Proteins - genetics | Influenza, Human - epidemiology | Mutation, Missense | Influenza A Virus, H1N1 Subtype - drug effects | Influenza A Virus, H1N1 Subtype - isolation & purification | Influenza A Virus, H3N2 Subtype - isolation & purification | Adamantane - therapeutic use | Influenza, Human - virology | Influenza A Virus, H3N2 Subtype - physiology | Influenza, Human - drug therapy | Oseltamivir - pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Structure-Based Discovery of the Novel Antiviral Properties of Naproxen against the Nucleoprotein of Influenza A Virus
by Nathalie Lejal and Bogdan Tarus and Edwige Bouguyon and Sylvie Chenavas and Nicolas Bertho and Bernard Delmas and Rob W. H. Ruigrok and Carmelo Di Primo and Anny Slama-Schwok
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2013, Volume 57, Issue 5, pp. 2231 - 2242
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
RNA-BINDING | MOLECULAR-DYNAMICS | IN-VITRO | INHIBITION | REPLICATION | H5N1 NUCLEOPROTEIN | AMINO-ACIDS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | IDENTIFICATION | OLIGOMERIZATION | MUTATIONAL ANALYSIS | Nucleoproteins - chemistry | Influenza A Virus, H3N2 Subtype - drug effects | Influenza A Virus, H3N2 Subtype - metabolism | Naproxen - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Viral Proteins - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | RNA, Viral - antagonists & inhibitors | Antiviral Agents - chemistry | Madin Darby Canine Kidney Cells | RNA, Viral - metabolism | Binding Sites | Influenza A Virus, H1N1 Subtype - metabolism | Orthomyxoviridae Infections - drug therapy | Antiviral Agents - pharmacology | Viral Proteins - chemistry | Viral Proteins - antagonists & inhibitors | Drug Repositioning | Influenza A Virus, H1N1 Subtype - drug effects | Drug Discovery | Molecular Dynamics Simulation | Nucleoproteins - antagonists & inhibitors | Naproxen - chemistry | Point Mutation | Animals | Influenza A Virus, H3N2 Subtype - chemistry | RNA, Viral - chemistry | Nucleoproteins - metabolism | Dogs | Protein Binding | Influenza A Virus, H1N1 Subtype - chemistry | Mice | Molecular Docking Simulation | Orthomyxoviridae Infections - virology | Anti-Inflammatory Agents, Non-Steroidal | Influenza A Virus, H3N2 Subtype | Nucleoproteins | Biochemistry, Molecular Biology | Viral Proteins | Antiviral Agents | Life Sciences | Naproxen | RNA, Viral | Influenza A Virus, H1N1 Subtype | Biomolecules | Orthomyxoviridae Infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Global Transmission of Oseltamivir-Resistant Influenza
by Moscona, Anne
The New England Journal of Medicine, ISSN 0028-4793, 03/2009, Volume 360, Issue 10, pp. 953 - 956
This winter, the circulating strain of seasonal influenza A virus (H1N1) is resistant to the neuraminidase inhibitor oseltamivir. Dr. Anne Moscona writes that... 
MEDICINE, GENERAL & INTERNAL | VIRUS NEURAMINIDASE | Influenza A Virus, H3N2 Subtype - drug effects | Antiviral Agents - therapeutic use | Oseltamivir - therapeutic use | Humans | Influenza, Human - transmission | Influenza A Virus, H1N1 Subtype - drug effects | Enzyme Inhibitors - therapeutic use | Influenza A Virus, H1N1 Subtype - ultrastructure | Drug Resistance, Viral - genetics | Influenza, Human - virology | Neuraminidase - antagonists & inhibitors | Influenza, Human - drug therapy | Mutation | Influenza A Virus, H1N1 Subtype - genetics | Drug therapy | Drug resistance in microorganisms | Swine influenza | Influenza | Drug use | Crystal structure
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase
by DIng, Yue and Cao, Zeyu and Cao, Liang and DIng, Gang and Wang, Zhenzhong and Xiao, Wei
Scientific Reports, ISSN 2045-2322, 04/2017, Volume 7, Issue 1, p. 45723
Lonicera japonica Thunb, rich in chlorogenic acid (CHA), is used for viral upper respiratory tract infection treatment caused by influenza virus, parainfluenza... 
BRONCHOALVEOLAR LAVAGE FLUID | IN-VITRO | CAFFEIC ACID | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | NEAR-INFRARED SPECTROSCOPY | CHINESE MEDICINE | VIRAL POLYMERASE | LONICERA-JAPONICA | BRONCHIAL-ASTHMA | FLOWER BUDS | Lung - pathology | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Influenza A Virus, H1N1 Subtype - drug effects | Antiviral Agents - administration & dosage | Lung - virology | Animals | Lung - drug effects | Dogs | Madin Darby Canine Kidney Cells | Female | Neuraminidase - antagonists & inhibitors | Mice, Inbred BALB C | Chlorogenic Acid - administration & dosage | Influenza, Human - prevention & control | Oseltamivir | Animal models | Intravenous administration | Influenza | Exo-a-sialidase | Antiviral activity | NP protein | Respiratory tract diseases | Chlorogenic acid | Immunofluorescence | Parainfluenza | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014
by Takashita, Emi and Meijer, Adam and Lackenby, Angie and Gubareva, Larisa and Rebelo-de-Andrade, Helena and Besselaar, Terry and Fry, Alicia and Gregory, Vicky and Leang, Sook-Kwan and Huang, Weijuan and Lo, Janice and Pereyaslov, Dmitriy and Siqueira, Marilda M and Wang, Dayan and Mak, Gannon C and Zhang, Wenqing and Daniels, Rod S and Hurt, Aeron C and Tashiro, Masato
Antiviral Research, ISSN 0166-3542, 05/2015, Volume 117, pp. 27 - 38
Four World Health Organization (WHO) Collaborating Centres for Reference and Research on Influenza and one WHO Collaborating Centre for the Surveillance,... 
Oseltamivir | Reduced susceptibility | Influenza virus | Neuraminidase inhibitors | Antiviral resistance | Global analysis | A(H1N1) VIRUS | H1N1 | VIROLOGY | COMMUNITY CLUSTER | JAPAN | H275Y OSELTAMIVIR-RESISTANT | PHARMACOLOGY & PHARMACY | MUTATIONS | Japan - epidemiology | United States - epidemiology | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Neuraminidase - genetics | Guanidines - pharmacology | Disease Outbreaks - statistics & numerical data | Influenza A Virus, H3N2 Subtype - genetics | Phylogeny | Microbial Sensitivity Tests | Influenza B virus - genetics | Zanamivir - analogs & derivatives | Time Factors | Neuraminidase - chemistry | Inhibitory Concentration 50 | Influenza B virus - drug effects | Influenza A Virus, H1N1 Subtype - genetics | Oseltamivir - pharmacology | Antiviral Agents - pharmacology | World Health Organization | Enzyme Inhibitors - pharmacology | Europe - epidemiology | Zanamivir - pharmacology | China - epidemiology | Cyclopentanes - pharmacology | Influenza A Virus, H1N1 Subtype - drug effects | Drug Resistance, Viral - genetics | Neuraminidase - antagonists & inhibitors | Amino Acid Substitution | Influenza viruses | Antiviral agents | Influenza
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights